Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5391)
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
1,171
Price
$653.68
Total Value
$765.45K
Shares Held After
101,716
% of Holdings
1.1%
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
1,669
Price
$652.49
Total Value
$1.09M
Shares Held After
102,887
% of Holdings
1.6%
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
1,095
Price
$651.49
Total Value
$713.38K
Shares Held After
104,556
% of Holdings
1.0%
IDEXX LABORATORIES INC /DE (IDXX)
MAZELSKY JONATHAN JAY — Director
Shares
1,281
Price
$650.67
Total Value
$833.51K
Shares Held After
105,651
% of Holdings
1.2%
AdaptHealth Corp. (AHCO)
Rew Richard W. II — CLO and General Counsel
Shares
5,000
Price
$8.91
Total Value
$44.55K
Shares Held After
107,097
% of Holdings
4.7%
MYRIAD GENETICS INC (MYGN)
Phanstiel S. Louise — Director
Shares
50,407
Price
$4.80
Total Value
$242.10K
Shares Held After
233,951
% of Holdings
21.5%
AbCellera Biologics Inc. (ABCL)
Thermopylae Holdings Ltd. — 10% Owner
Shares
177,457
Price
$3.27
Total Value
$580.28K
Shares Held After
56,096,097
% of Holdings
0.3%
HENRY SCHEIN INC (HSIC)
BERGMAN STANLEY M — Director
Shares
7,212
Price
$81.51
Total Value
$587.85K
Shares Held After
427,615
% of Holdings
1.7%
HENRY SCHEIN INC (HSIC)
BERGMAN STANLEY M — Director
Shares
31,134
Price
$80.90
Total Value
$2.52M
Shares Held After
434,827
% of Holdings
6.7%
BridgeBio Pharma, Inc. (BBIO)
Apuli Maricel — Chief Accounting Officer
Shares
2,000
Price
$66.00
Total Value
$132.00K
Shares Held After
121,945
% of Holdings
1.6%
Wave Life Sciences Ltd. (WVE)
Francis Chris — SVP, Corporate Development, Head of Emerging Areas
Shares
15,294
Price
$15.00
Total Value
$229.41K
Shares Held After
61,867
% of Holdings
19.8%
Wave Life Sciences Ltd. (WVE)
Francis Chris — SVP, Corporate Development, Head of Emerging Areas
Shares
17,900
Price
$15.09
Total Value
$270.18K
Shares Held After
61,867
% of Holdings
22.4%
Axsome Therapeutics, Inc. (AXSM)
Coleman Mark — Director
Shares
25,000
Price
$161.11
Total Value
$4.03M
Shares Held After
47,140
% of Holdings
34.7%
Axsome Therapeutics, Inc. (AXSM)
Jacobson Mark L. — Chief Operating Officer
Shares
35,378
Price
$161.88
Total Value
$5.73M
Shares Held After
0
% of Holdings
100.0%
BECTON DICKINSON & CO (BDX)
Feld Michael — EVP, Chief Revenue Officer
Shares
75
Price
$181.84
Total Value
$13.64K
Shares Held After
21,308
% of Holdings
0.4%
IDEXX LABORATORIES INC /DE (IDXX)
Hunt Nimrata — Executive Vice President
Shares
2,693
Price
$661.54
Total Value
$1.78M
Shares Held After
19,899
% of Holdings
11.9%
Neuronetics, Inc. (STIM)
Sullivan Keith J — Director
Shares
8,452
Price
$1.35
Total Value
$11.41K
Shares Held After
1,524,713
% of Holdings
0.6%
Neuronetics, Inc. (STIM)
MACAN WILLIAM ANDREW — EVP, CLO and CS
Shares
3,427
Price
$1.35
Total Value
$4.63K
Shares Held After
880,134
% of Holdings
0.4%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
16,313
Price
$7.01
Total Value
$114.29K
Shares Held After
154,657
% of Holdings
9.5%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
17,924
Price
$34.44
Total Value
$617.30K
Shares Held After
174,144
% of Holdings
9.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
165,408
Price
$33.63
Total Value
$5.56M
Shares Held After
477,783
% of Holdings
25.7%
BIOMARIN PHARMACEUTICAL INC (BMRN)
Davis George Eric — EVP, Chief Legal Officer
Shares
26,061
Price
$61.36
Total Value
$1.60M
Shares Held After
72,453
% of Holdings
26.5%
BIOMARIN PHARMACEUTICAL INC (BMRN)
Friberg Gregory R — EVP, Chief R&D Officer
Shares
6,326
Price
$60.38
Total Value
$381.94K
Shares Held After
37,578
% of Holdings
14.4%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
711
Price
$54.28
Total Value
$38.59K
Shares Held After
1,480
% of Holdings
32.5%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
6,329
Price
$53.67
Total Value
$339.67K
Shares Held After
2,191
% of Holdings
74.3%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
2,638
Price
$276.32
Total Value
$728.92K
Shares Held After
85,096
% of Holdings
3.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
5,103
Price
$275.28
Total Value
$1.40M
Shares Held After
87,734
% of Holdings
5.5%
Sintx Technologies, Inc. (SINT)
Lyons Christopher Michael — Director
Shares
758
Price
$2.96
Total Value
$2.24K
Shares Held After
758
% of Holdings
100.0%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
12,378
Price
$23.86
Total Value
$295.34K
Shares Held After
639,076
% of Holdings
1.9%
10x Genomics, Inc. (TXG)
Teichmann Sarah A. — Director
Shares
7,579
Price
$19.41
Total Value
$147.11K
Shares Held After
26,780
% of Holdings
22.1%
Caribou Biosciences, Inc. (CRBU)
Kelly Timothy P — Chief Technology Officer
Shares
6,228
Price
$1.93
Total Value
$12.02K
Shares Held After
73,125
% of Holdings
7.8%
MYRIAD GENETICS INC (MYGN)
Phanstiel S. Louise — Director
Shares
6,100
Price
$4.74
Total Value
$28.89K
Shares Held After
183,544
% of Holdings
3.3%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
523
Price
$18.04
Total Value
$9.43K
Shares Held After
209,641
% of Holdings
0.2%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
3,108
Price
$18.04
Total Value
$56.07K
Shares Held After
210,164
% of Holdings
1.5%
AbbVie Inc. (ABBV)
Siatis Perry C — EVP, GC AND SECRETARY
Shares
22,381
Price
$230.00
Total Value
$5.15M
Shares Held After
38,137
% of Holdings
37.0%
uniQure N.V. (QURE)
KLEMT CHRISTIAN — Chief Financial Officer
Shares
6,217
Price
$23.86
Total Value
$148.34K
Shares Held After
211,513
% of Holdings
2.9%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
942
Price
$28.90
Total Value
$27.22K
Shares Held After
170,273
% of Holdings
0.6%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
859
Price
$28.16
Total Value
$24.19K
Shares Held After
171,215
% of Holdings
0.5%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
1,437
Price
$26.98
Total Value
$38.77K
Shares Held After
172,074
% of Holdings
0.8%
Gemini Therapeutics, Inc. (GMTX)
Franchi Jean M. — Chief Financial Officer
Shares
353
Price
$69.06
Total Value
$24.38K
Shares Held After
70,990
% of Holdings
0.5%
Q32 Bio Inc. (QTTB)
Kalowski Lee — CFO and President
Shares
3,995
Price
$4.51
Total Value
$18.04K
Shares Held After
35,943
% of Holdings
10.0%
Q32 Bio Inc. (QTTB)
Morrison Jodie Pope — Director
Shares
9,896
Price
$4.51
Total Value
$44.67K
Shares Held After
89,104
% of Holdings
10.0%
Q32 Bio Inc. (QTTB)
Violette Shelia M. — Chief Scientific Officer
Shares
2,815
Price
$4.51
Total Value
$12.71K
Shares Held After
55,569
% of Holdings
4.8%
GLOBUS MEDICAL INC (GMED)
Huller Kelly — EVP, GC, Corporate Secretary
Shares
20,000
Price
$94.50
Total Value
$1.89M
Shares Held After
0
% of Holdings
100.0%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
33,687
Price
$7.00
Total Value
$235.96K
Shares Held After
170,970
% of Holdings
16.5%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
2,000
Price
$1.49
Total Value
$2.98K
Shares Held After
1,906,186
% of Holdings
0.1%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
1,300
Price
$36.68
Total Value
$47.68K
Shares Held After
459,859
% of Holdings
0.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
10,436
Price
$35.96
Total Value
$375.28K
Shares Held After
461,159
% of Holdings
2.2%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
46,517
Price
$35.11
Total Value
$1.63M
Shares Held After
471,595
% of Holdings
9.0%
Edwards Lifesciences Corp (EW)
BOBO DONALD E JR — CVP,Strategy/Corp Development
Shares
24,000
Price
$83.84
Total Value
$2.01M
Shares Held After
21,266
% of Holdings
53.0%
Showing 2251–2300 of 5391 transactions (page 46 of 108)